Quick Answer
CORCEPT THERAPEUTICS INC reported Net Income of $99.65 million for fiscal year 2025.
CORCEPT THERAPEUTICS INC Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | $99.65M | -29.4% |
| 2024 | $141.21M | +33.0% |
| 2023 | $106.14M | +4.7% |
| 2022 | $101.42M | -9.9% |
| 2021 | $112.51M | +6.1% |
| 2020 | $106.01M | +12.6% |
| 2019 | $94.18M | +24.9% |
| 2018 | $75.41M | -41.6% |
| 2017 | $129.12M | +1486.3% |
| 2016 | $8.14M | +227.0% |
| 2015 | -$6.41M | +79.6% |
| 2014 | -$31.38M | +31.8% |
| 2013 | -$46.01M | -20.9% |
| 2012 | -$38.05M | -17.6% |
| 2011 | -$32.35M | -24.6% |
| 2010 | -$25.97M | -28.8% |
| 2009 | -$20.17M | -0.5% |
| 2008 | -$20.06M | -73.3% |
| 2007 | -$11.57M | +53.5% |
| 2006 | -$24.87M | -23.8% |
| 2005 | -$20.09M | -29.3% |
| 2004 | -$15.54M | -58.3% |
| 2003 | -$9.81M | +47.0% |
| 2002 | -$18.50M | -148.2% |
| 2001 | -$7.45M | -303.8% |
| 2000 | -$1.85M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $19.67M | -58.3% | -44.0% |
| June 30, 2025 | $35.15M | -1.0% | +71.1% |
| March 31, 2025 | $20.55M | -26.0% | -56.5% |
| September 30, 2024 | $47.21M | +50.5% | +33.0% |
| June 30, 2024 | $35.49M | +28.9% | +27.8% |
| March 31, 2024 | $27.76M | +74.8% | -11.5% |
| September 30, 2023 | $31.38M | -9.3% | +14.0% |
| June 30, 2023 | $27.53M | +0.4% | +73.4% |
- CORCEPT THERAPEUTICS INC showed a decrease of -29.4% in Net Income compared to the prior fiscal year.
- Over the 2000–2025 period, CORCEPT THERAPEUTICS INC’s net income has grown by 5498.3% (from -$1.85 million to $99.65 million).
- The most recent figure is from CORCEPT THERAPEUTICS INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: